MedTrace Logo

Osteopathic Manual Therapy Versus Ganglion Impar Block for Chronic Coccygodynia

NCT07642167 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 100

Last updated 2026-06-11

No results posted yet for this study

Summary

The goal of this clinical trial is to compare two treatment methods for chronic coccygodynia (tailbone pain) in adults. The study aims to determine which treatment provides better pain relief and functional improvement.

The main questions it aims to answer are:

Does osteopathic manual therapy reduce pain and disability in people with chronic coccygodynia?

Does ganglion impar block reduce pain and disability in people with chronic coccygodynia?

Which treatment provides more sustained improvement during follow-up?

Researchers will compare osteopathic manual therapy with ganglion impar block to evaluate their effects on pain, function, quality of life, and patient satisfaction.

Participants will:

Be randomly assigned to one of the two treatment groups.

Receive either osteopathic manual therapy or ganglion impar block.

Complete pain, disability, neuropathic pain, and quality-of-life assessments before treatment and during follow-up visits.

Attend follow-up evaluations at 3 weeks and 3 months after treatment.

Conditions

  • Chronic Coccygodynia

Interventions

PROCEDURE

Osteopathic Manual Therapy

A 6-week osteopathic manual therapy program including coccygeal mobilization, levator ani muscle techniques, myofascial release, and neural stretching exercises.

PROCEDURE

Ganglion Impar Block

A fluoroscopy-guided ganglion impar block performed with local anesthetic and corticosteroid injection for pain management in chronic coccygodynia.

Sponsors & Collaborators

  • Atlas University

    lead OTHER

Principal Investigators

  • mert sancar, MD · Istanbul Atlas University Faculty of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-08-28
Primary Completion
2026-03-12
Completion
2026-04-02

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07642167 on ClinicalTrials.gov